methamphetamine has been researched along with Wallerian Degeneration in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, L; Cloak, CC; Ernst, T; Fujii, L; Hedemark, B | 1 |
| Govitrapong, P; Kaewsuk, S; Phansuwan-Pujito, P; Sae-ung, K | 1 |
| Ares-Santos, S; Cuadrado, A; Granado, N; Lastres-Becker, I; Martin, E; Moratalla, R; Oliva, I | 1 |
3 other study(ies) available for methamphetamine and Wallerian Degeneration
| Article | Year |
|---|---|
Lower diffusion in white matter of children with prenatal methamphetamine exposure.
Topics: Abnormalities, Drug-Induced; Anisotropy; Atrophy; Brain; Central Nervous System Stimulants; Child, Preschool; Cognition Disorders; Corpus Callosum; Dendritic Spines; Diffusion; Diffusion Magnetic Resonance Imaging; Female; Humans; Intelligence; Male; Methamphetamine; Nerve Fibers, Myelinated; Neuropsychological Tests; Pregnancy; Prenatal Exposure Delayed Effects; Wallerian Degeneration | 2009 |
Melatonin attenuates methamphetamine-induced reduction of tyrosine hydroxylase, synaptophysin and growth-associated protein-43 levels in the neonatal rat brain.
Topics: Amphetamine-Related Disorders; Animals; Animals, Newborn; Antioxidants; Brain; Brain Chemistry; Central Nervous System Stimulants; Dopamine; Down-Regulation; Drug Interactions; Female; GAP-43 Protein; Melatonin; Methamphetamine; Neuroprotective Agents; Pregnancy; Prenatal Exposure Delayed Effects; Presynaptic Terminals; Rats; Rats, Wistar; Synaptophysin; Tyrosine 3-Monooxygenase; Wallerian Degeneration | 2009 |
Nrf2 deficiency potentiates methamphetamine-induced dopaminergic axonal damage and gliosis in the striatum.
Topics: Adrenergic Uptake Inhibitors; Animals; Axons; Corpus Striatum; Disease Models, Animal; Dopamine; Gliosis; Inflammation Mediators; Male; Methamphetamine; Mice; Mice, Knockout; NF-E2-Related Factor 2; Wallerian Degeneration | 2011 |